Abstract：
:First-generation adenoviral (Ad) vectors are frequently used vectors for experimental and clinical gene transfer. Earlier it has been shown that parallel overexpression of the cell cycle regulator p21(Waf1/Cip1) (p21) or antiapoptotic bcl-2 from a second vector reduces cytotoxicity and improves transgene expression. Here, we investigate whether the co-expression of p21 and alpha(1)-antitrypsin from a single vector improves vector safety and alpha(1)-antitrypsin expression. Cell lines (A549 and HeLa) and primary cells (small airway epithelial cells and hepatocytes) were infected with adenovirus vectors transducing alpha(1)-antitrypsin with (AdCMV.p21-RSV.hAAT) or without (AdRSV.hAAT) p21. alpha(1)-Antitrypsin expression and cytotoxicity were analyzed using western blot/ELISA and LDH/ALT/AST assays, respectively. Cell cycle profiles were determined by flow cytometry. Co-expression of p21 strongly increased the alpha(1)-antitrypsin expression in all cell types and at all doses tested. No changes in ALT/AST from hepatocytes and only minor increases in the LDH release in A549 and HeLa were observed with either vector. Cell cycle profiles were also not affected adversely. Incorporation of p21 in Ad vectors together with a gene of interest improves the vector performance; such vectors will allow the application of lower doses and thereby reduce immunological side effects.
journal_name
Gene Therjournal_title
Gene therapyauthors
Schumacher A,Horvat S,Woischwill C,Wolff G,Witt Cdoi
10.1038/gt.2009.2subject
Has Abstractpub_date
2009-04-01 00:00:00pages
574-8issue
4eissn
0969-7128issn
1476-5462pii
gt20092journal_volume
16pub_type
杂志文章相关文献
GENE THERAPY文献大全abstract：:Adenovirus-mediated gene transfer of interferon gamma (AdIFN) elicits rejection of intracerebral Lewis lung carcinoma. In this system, gene transfer into brain parenchymal cells is both necessary and sufficient to generate the antitumor response. Despite persistent parenchymal inflammation and demyelination, wild-type...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301346
更新日期：2000-12-01 00:00:00
abstract：:Low levels of expression in haemopoietic cells of the DNA repair protein O6-alkylguanine-DNA alkyltransferase (A Tase), is associated with the dose-limiting sensitivity of these cells to the chemotherapeutic chloroethylating and related methylating agents. Thus, the use of agents which deplete ATase such as O6-benzylg...
journal_title：Gene therapy
pub_type： 杂志文章
doi：
更新日期：1996-10-01 00:00:00
abstract：:Tissue-specific promoters for gene therapy are typically too big for adeno-associated virus (AAV) vectors; thus, the exploration of small effective non-viral regulatory elements is of particular interest. Wild-type AAV can specifically integrate into a region on human chromosome 19 termed AAVS1. Earlier work has deter...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2008.134
更新日期：2009-01-01 00:00:00
abstract：:The majority of immunotherapy-based gene therapy protocols consist of ex vivo gene transfer in tumor cells. To prevent further in vivo growth, modified cells must be irradiated before reinjection into patients. The present study examines the effects of gamma-irradiation on transgene expression in transduced leukemic c...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301870
更新日期：2003-02-01 00:00:00
abstract：:We have shown that various forms of oligonucleotides, chimeric RNA-DNA oligonucleotide (RDO) and single-stranded oligodeoxynucleotide (ODN), are capable of chromosomal gene alterations in mammalian cells. Using two ODNs we corrected an inactivating mutation in the tyrosinase gene and introduced an activating mutation ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301862
更新日期：2002-12-01 00:00:00
abstract：:Integration site analysis was performed on six dogs with canine leukocyte adhesion deficiency (CLAD) that survived greater than 1 year after infusion of autologous CD34+ bone marrow cells transduced with a gammaretroviral vector expressing canine CD18. A total of 387 retroviral insertion sites (RIS) were identified in...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2008.52
更新日期：2008-07-01 00:00:00
abstract：:Gene transfer complexes containing poly-L-lysine (poly-K) and DNA with ligands directed at the serpin enzyme complex receptor (sec-R) deliver reporter genes to receptor-bearing cells in vivo. Expression lasts for about 30 days, when complexes containing long-chain poly-K are used. Extending the duration of expression ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302299
更新日期：2004-09-01 00:00:00
abstract：:Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system (CNS), where suspected autoimmune attack causes nerve demyelination and progressive neurodegeneration and should benefit from both anti-inflammatory and neuroprotective strategies. Although neuroprotection strategies are relatively une...
journal_title：Gene therapy
pub_type： 杂志文章,评审
doi：10.1038/sj.gt.3302025
更新日期：2003-05-01 00:00:00
abstract：:This work demonstrates that electrical muscle stimulation markedly increases the transfection efficiency of an intramuscular injection of plasmid DNA. In soleus or extensor digitorum longus muscles of adult rats the percentage of transfected fibers increased from about 1 to more than 10. The number of transfected fibe...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300847
更新日期：1999-04-01 00:00:00
abstract：:Success of gene therapy for diseases affecting the T cell lineage depends on the thymic repopulation by genetically engineered hematopoietic progenitor cells (HPC). Although it has been shown that retrovirally transduced HPC can repopulate the thymus, little information is available on the effect of the culture protoc...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301176
更新日期：2000-05-01 00:00:00
abstract：:A novel class of cationic hyperbranched polymers, containing branched oligoethylenimine (OEI 800 Da) as core, diacrylate esters as linkers and oligoamines as surface modification, was synthesized and evaluated regarding their structure-activity relationship as gene carriers. We show that pseudodendritic core character...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3303046
更新日期：2008-01-01 00:00:00
abstract：:Adeno-associated virus (AAV) gene therapy constitutes a powerful tool for the treatment of neurodegenerative diseases. While AAVs are generally administered systemically to newborns in preclinical studies of neurological disorders, in adults the maturity of the blood-brain barrier (BBB) must be considered when selecti...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2017.18
更新日期：2017-05-01 00:00:00
abstract：:The possibility of achieving multiple systemic expression of human interferon-beta in mice upon repeated intravenous administration of cationic liposome-DNA complex (lipoplex) was investigated. Lipoplexes containing the pentammonio lipid pcTG90 were first optimized by selecting the most efficient ratio of pcTG90 to ph...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301289
更新日期：2000-09-01 00:00:00
abstract：:By-pass surgery and percutaneous transluminal (coronary) angioplasty, PT(C)A, are standard techniques for the treatment of vascular occlusions. Their usefulness is limited by by-pass graft failure and restenosis occurring after the procedures. Twenty percent of patients treated with PTCA/PTA need a new revascularizati...
journal_title：Gene therapy
pub_type： 杂志文章,评审
doi：10.1038/sj.gt.3301866
更新日期：2002-11-01 00:00:00
abstract：:In 2012, we reported that 5 out of 11 subjects in a clinical trial (NCT00372320) administering AdhAQP1 to radiation-damaged parotid glands showed increased saliva flow rates and decreased symptoms over the initial 42 days. AdhAQP1 is a first-generation, E1-deleted, replication-defective, serotype 5 adenoviral vector e...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2015.55
更新日期：2015-09-01 00:00:00
abstract：:Newcastle disease virus (NDV) is an oncolytic paramyxovirus with a nonsegmented single-stranded RNA genome. In this report, a recombinant oncolytic NDV was passaged in human tumor xenografts and reisolated and characterized after two rounds of bioselection. Several isolates could be recovered that differed from the pa...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2012.13
更新日期：2013-01-01 00:00:00
abstract：:Both replication-incompetent and replication-selective adenoviruses are being developed for the treatment of cancer and other diseases. Concerns have been raised about the safety of intra-vascular adenovirus administration following a patient death on a clinical trial with a replication-defective adenovirus. In additi...
journal_title：Gene therapy
pub_type： 临床试验,杂志文章
doi：10.1038/sj.gt.3301512
更新日期：2001-11-01 00:00:00
abstract：:The mouse is widely used as a model for DNA therapy and vaccination even though the efficiency of DNA delivery in higher mammals and humans is much less. The human APOBEC3 (A3) enzymes impact viral genomes by cytidine deamination, which introduces multiple uridine residues into single-stranded DNA, a process known as ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2014.88
更新日期：2015-01-01 00:00:00
abstract：:We report on long-term delivery of an interferon-gamma (IFN gamma) inhibitory protein by intramuscular (i.m.) gene therapy. IFN gamma is a cytokine that plays an important role in many inflammatory disorders, including autoimmune insulin-dependent diabetes mellitus (IDDM) in NOD mice and (in various strains) multiple ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300879
更新日期：1999-05-01 00:00:00
abstract：:Relaxin-3 is a neuropeptide that is abundantly expressed by discrete brainstem neuron populations that broadly innervate forebrain areas rich in the relaxin-3 G-protein-coupled-receptor, RXFP3. Acute and subchronic central administration of synthetic relaxin-3 or an RXFP3-selective agonist peptide, R3/I5, increase fee...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2012.83
更新日期：2013-07-01 00:00:00
abstract：:Gene targeting by single-stranded oligodeoxyribonucleotides (ssODNs) is a promising technique for introducing site-specific sequence alterations without affecting the genomic organization of the target locus. Here, we discuss the significant progress that has been made over the last 5 years in unraveling the mechanism...
journal_title：Gene therapy
pub_type： 杂志文章,评审
doi：10.1038/gt.2010.161
更新日期：2011-03-01 00:00:00
abstract：:Viral gene vectors often rely on packaging cell lines, which provide the necessary factors in trans for the formation of virus-like particles. Previously, we reported on a first-generation packaging cell line for gene vectors, which are based on the B-lymphotropic Epstein-Barr virus (EBV), a human gamma-herpesvirus. T...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302714
更新日期：2006-05-01 00:00:00
abstract：:Alveolar bone loss associated with periodontal diseases is the result of osteoclastogenesis induced by bacterial pathogens. The mitogen-activated protein kinase (MAPK) phosphatase 1 (MKP-1) is a critical negative regulator of immune response as a key phosphatase capable of dephosphorylating activated MAPKs. In this st...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2010.139
更新日期：2011-04-01 00:00:00
abstract：:With the long-term goal of developing a gene-based treatment for osteoarthritis (OA), we performed studies to evaluate the equine joint as a model for adeno-associated virus (AAV)-mediated gene transfer to large, weight-bearing human joints. A self-complementary AAV2 vector containing the coding regions for human inte...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2012.81
更新日期：2013-06-01 00:00:00
abstract：:T-cell dysfunction is thought to be central to the immunodeficiency state seen in patients with the Wiskott-Aldrich syndrome (WAS). Aspects of the WAS phenotype have been corrected in other cell types on introduction of the normal WAS protein (WASP), but the potential for correction of the T-cell defects has not been ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301950
更新日期：2003-05-01 00:00:00
abstract：:Mobilized blood CD34+ cells from cancer patients were ex vivo infected by a recombinant adenovirus vector carrying an alkaline phosphatase gene, whose expression is evaluable by flow cytometry. A mean of 40% CD34+ cells were infected by the vector, with high levels of expression of the transgene. Among attempts to imp...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300620
更新日期：1998-04-01 00:00:00
abstract：:A stable packaging cell line (Vero/BC-F) constitutively expressing fusion (F) protein of the human parainfluenza virus type 2 (hPIV2) was established for production of the F-defective and single round-infectious hPIV2 vector in a strategy for recombinant vaccine development. The F gene expression has not evoked cytost...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2014.55
更新日期：2014-08-01 00:00:00
abstract：:A replication-incompetent adenoviral vector encoding the heavy chain C-fragment (H(C)50) of botulinum neurotoxin type C (BoNT/C) was evaluated as a mucosal vaccine against botulism in a mouse model. Single intranasal inoculation of the adenoviral vector elicited a high level of H(C)50-specific IgG, IgG1 and IgG2a in s...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2008.181
更新日期：2009-03-01 00:00:00
abstract：:Insulin gene therapy in clinical medicine is currently hampered by the inability to regulate insulin secretion in a physiological manner, the inefficiency with which the gene is delivered, and the short duration of gene expression. To address these issues, we injected the liver of streptozotocin-induced diabetic rats ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302644
更新日期：2006-02-01 00:00:00
abstract：:Gene therapy with viral vectors has progressed to clinical trials. However, the localization of viral vector delivery to diseased target sites remains a challenge. We tested the hypothesis that an adenoviral vector could be successfully delivered by complexation with a specific antibody that is bound to a biodegradabl...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301452
更新日期：2001-05-01 00:00:00
